Page URL: https://www.bionews.org.uk/page_91831

Disgraced Korean scientist faces four years in prison

1 September 2009
Appeared in BioNews 523

Disgraced South Korean stem cell scientist, Hwang Woo-Suk found last Monday that he faces a possible four year jail term for alleged embezzlement, and the violation of South Korean bioethics laws. Hwang, once a leading scientist at Seoul National University (SNU) in the field of stem cell research, scandalised the Korean and international scientific community when it was discovered that his so-called pioneering work was, in fact, a fraud.

In 2004 and 2005 Hwang published papers in the journal Science claiming to have produced the world's first cloned human embryonic stem cell line and further that he and his team had succeeded in creating 11 other stem cell-lines from cloned embryos. SNU was forced to investigate these research claims after suspicions were raised by scientists in the field and both claims were found to be false.

Hwang was subsequently fired from his post as professor at SNU, banned from undertaking further research in human stem-cell research and indicted in March 2006. It is alleged that Hwang embezzled at least 800 million won from government grants (then worth about $2.1 million) and that he illegally paid junior members of his female staff to donate their own eggs for his research.

In a hearing in July 2006, Hwang admitted that he fabricated data, but claimed that he was misled by younger researchers. He denies that he embezzled research funds, claiming that the money was properly used on the research it was applied for. Hwang has pleaded to the court for leniency, expressing that he wishes to devote his remaining time to research. Indeed, despite this scandal Hwang has continued work, successfully cloning a dog in 2005 (a result which was independently verified). In April this year the government conditionally lifted the ban preventing him from engaging in human stem cell research. Later, in June he was awarded the Jang Yeong-sil prize for Scientist of the Year.

The court is expected to deliver a ruling on 19 October 2009.

SOURCES & REFERENCES
4-year jail sentence demanded on Hwang
Korea Herald |  28 August 2009
4-Year Jail Term Sought for Stem Cell Fraud
Korea Times |  24 August 2009
Disgraced South Korean Cloning Scientist May Face Jail Time
Discover magazine |  24 August 2009
SKorea seeks jail for disgraced cloning scientist
Associated Press |  24 August 2009
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
19 March 2012 - by Dr Sophie Pryor 
A cardiologist in Bonita Springs, Florida, USA, has had his medical licence suspended after allegedly performing an illegal stem cell treatment on a patient who died during the procedure...
10 October 2011 - by Dr Louisa Petchey 
US scientists have for the first time created 'personalised' human embryonic stem cells (hESCs) using a form of cloning. The result is a significant milestone on the route to using stem cell-based therapies but the researchers stress more work is to be done as genetic errors in the cells means they are not yet suitable for therapeutic use....
8 November 2010 - by Dr Jay Stone 
International journal Nature has found no sign of fraud in a 2009 paper published by Professor Konrad Hochedlinger and colleagues. The allegations came from a group calling itself 'Stem Cell Watch' which has made a series of accusations of fraud against a number of leading stem cell scientists, including Professor Hochedlinger, citing repetition and the manipulation of images among its reasons for concern....
27 September 2010 - by Dr Jay Stone 
Questions continue to be asked after Dr Savio Woo, a gene therapist at the Mount Sinai School of Medicine in New York, was forced to retract two more of his papers last week. Dr Woo has retracted six papers this year after two of his post-docs, Li Chen and Zhiyu Li, were accused of scientific misconduct....
31 August 2010 - by Dr Nadeem Shaikh 
Maurice Wilkins won the Nobel Prize for Medicine with James Watson and Francis Crick in 1962, for the pioneering work in deciphering the structure of the DNA helix. Files recently released to the National Archives now reveal that he was previously being investigated for being a potential communist sympathiser and betraying secrets from his work on the first nuclear bomb...
3 May 2009 - by Heidi Colleran 
South Korea's Presidential Committee on Bioethics has granted the first human embryonic stem (ES) cell research licence since their preeminent research scientist fell spectacularly from grace amidst allegations of scientific fraud and embezzlement, over three years ago. Cha Medical Center in the South Korean capital, Seoul, has...
6 October 2008 - by MacKenna Roberts 
The Australian Patent Office, IP Australia, are expected to grant a patent to internationally disgraced South Korean Scientist Hwang Woo-Suk for his human cloning technology which he fraudulently claimed led to false scientific achievements in 2005. Hwang is one of 18 researchers named on the patent application...
4 August 2008 - by Antony Starza-Allen 
The South Korean Health Ministry has rejected a licence application to carry out stem cell research made by the company owned by disgraced stem cell scientist, Hwang Woo-Suk, citing 'ethical problems'. The Suam Biotech Research Foundation had requested approval last December to resume its research on human...
27 May 2008 - by Antony Starza-Allen 
US company BioArts International has teamed up with disgraced South Korean scientist Hwang Woo-Suk to offer dog cloning services to the public. Five dog owners will be given the opportunity to have their pet cloned in a worldwide auction on 18 June this year, where bidding will...
6 August 2007 - by Antony Starza-Allen 
The disgraced South Korean stem cell scientist, Woo Suk Hwang, whose spectacular fall from grace dominated the newspaper headlines early last year, has been credited with 'accidentally' creating the world's fisrt stem cells produced from an unfertilised human egg. An international collaboration of scientists last week published...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.